Company profile

Nightware, Inc.

nightware.comHeadquarters: United States
Product Vendor
Nightware, Inc. logo

Primary focus

Prescription digital therapeutics for reducing sleep disturbance related to Nightmare Disorder and PTSD-related nightmares.

Why it’s included

The company develops and manufactures an FDA-cleared prescription digital therapeutic system explicitly indicated for PTSD-related nightmares, supported by its own clinical trials, patents, and Department of Defense-funded PTSD research.

Relevant capabilities

  • Real-time AI-driven detection of nightmare events with adaptive haptic intervention
  • Integration with wearable biometric sensors and mobile devices
  • Randomized, double-blind, sham-controlled clinical trial design and execution
  • Regulatory submissions and interactions with FDA including Breakthrough Device pathway
  • Clinical outcome measurement and clinical data analysis
Commercial sectorDigital Therapeutics, VR Exposure, and Wearable Devices
Technology classesDigital therapeutics for PTSD nightmares

Relevant commercial products

  • Prescription digital therapeutic wearable kit for reducing nightmare-related sleep disturbance
  • Trauma Related Nightmare Survey
  • Nightmare Disorder Index
  • Insomnia Severity Index
  • Patient Health Questionnaire

Relevant patents

2 families, 5 publications
  • Traumatic nightmare detection and intervention US-10765831-B1
  • Systems and methods for automated stress monitoring and intervention US-12070326-B2

← Back to what’s inside this report